Evaluation of the Effect of Sildenafil Nutrition on the Treatment of Injection Routine (Milirinone) in Infants with Pulmonary Hypertensio

Phase 3

Recruiting

• Conditions: Pulmonary hypertension.; Primary pulmonary hypertension; I27.0

• Registration Number: IRCT20190731044393N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Infants hospitalized in neonatal wards of Afzalipour Hospital
Parental Satisfaction
Gestational age greater than or equal to 34 weeks
Confirmation of diagnosis of high blood pressure by echocardiography

Exclusion Criteria

Congenital heart disease
The birth of a major anomaly

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evidence of pulmonary hypertension. Timepoint: The first day and 72 hours later. Method of measurement: Eco cardiography.